ACGL three-lens brief
Evidence-based stock research on ACGL. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 9.2pp over 30 days. · Debt-to-equity of 11.3 — balance-sheet-heavy.
- Underperforming SPY by 9.2pp over 30 days.
- P/E of 7.2 — trading at a value multiple.
- Analyst mean target $109.39 — 16% above current (19 analysts).
- Debt-to-equity of 11.3 — balance-sheet-heavy.
- 8-K filing filed 2026-04-28.
ACGL closed at $94.19 (+0.39%) as of 2026-05-04. Market cap: $33.27B. P/E (trailing) 7.2. Positives: p/E of 7.2 — trading at a value multiple.; analyst mean target $109.39 — 16% above current (19 analysts).. Concerns: underperforming SPY by 9.2pp over 30 days.; debt-to-equity of 11.3 — balance-sheet-heavy.. Last quarter: Revenue $4.35B, net income $1.04B, free cash flow $6.26B.
Why three lenses on ACGL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACGLacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACGL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACGL brief"></iframe>